Concepedia

H. Hayashi

HH

4

Publications

103

Citations

4

H-Index

1999

Active since

Affiliations

Kindai University(Current)

The University of Texas MD Anderson Cancer Center

Université Toulouse III - Paul Sabatier

Seoul National University Hospital

Seoul National University

H. Hayashi is an author at Kindai University specializing in medicine, pharmacology, and molecular medicine.

Top concepts

MedicinePharmacologyPhysicsOncologyEngineeringTumor BiologyNuclear PhysicsNatural SciencesMolecular BiologyNeutron Transport

Publications per year

1999–2024

4

Publications

4

Multimodal analysis of prompt neutron spectra for 237Np(n,f)

Takaaki Ohsawa, Tetsuo Horiguchi, H. Hayashi · Nuclear Physics A · 1999 · 42 citations

Engineering, Nuclear Physics, Physics +6

LBA52 Tepotinib + osimertinib for EGFRm NSCLC with MET amplification (METamp) after progression on first-line (1L) osimertinib: Initial results from the INSIGHT 2 study

Julien Mazières, T.M. Kim, Boon Khaw Lim et al. · Annals of Oncology · 2022 · 40 citations

Oncology, Met Amplification, Egfrm Nsclc +5

OA21.05 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis

T.M. Kim, Valentina Guarneri, V. Pei Jye et al. · Journal of Thoracic Oncology · 2023 · 11 citations · Full text

Met Amplification, Medicine, Molecular Biology +5

PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations

X. Le, Y. Zhao, D. Planchard et al. · Journal of Thoracic Oncology · 2024 · 10 citations · Full text

Rows per page

1–4 of 4